Abstract
Because of the multi-functional characteristics and bioadaptability, cyclodextrin (CyD) is capable of alleviating the undesirable properties of drug molecules through the formation of inclusion complexes. This paper outlines the current application of natural and chemically modified CyDs in the various pharmaceutical formulations including peptide and protein drugs. Furthermore, potential use of CyD/drug conjugates in site-specific drug delivery is discussed.
Similar content being viewed by others
REFERENCES
J. Szejtli and T. Osa: Comprehensive Supramolecular Chemistry, Vol. 3, Pergamon Press, Oxford (1996).
R.A. Rajewski and V.J. Stella: J. Pharm. Sci. 85, 1142 (1996). K. Uekama, F. Hirayama and T. Irie: Chem. Rev. 98, 2045 (1998).
T. Loftsson, M.E. Brewster: J. Pharm. Sci. 85, 1017 (1996).
F. Hirayama, S. Mieda, Y. Miyamoto, H. Arima and K. Uekama: J. Pharm. Sci. 88, 970 (1999).
N. Ono, H. Arima, F. Hirayama and K. Uekama: Biol. Pharm. Bull. 24, 395 (2001).
F. Hirayama and K. Uekama: Advn. Drug Delivery Rev. 36, 125 (1999).
T. Irie and K. Uekama: Advn. Drug Delivery Rev. 36, 101 (1999).
K. Okimoto, A. Ohike, R. Ibuki, N. Ohnishi, R.A. Rajewski, V.J. Stella, T. Irie and K. Uekama: Pharm. Res. 16, 549 (1999).
K. Kimura, F. Hirayama, H. Arima and K. Uekama: Chem. Pharm. Bull. 48, 646 (2000).
F. Hirayama, K. Zaoh, K. Harata, W. Saenger and K. Uekama: Chem. Lett.2001, 636.
O.A. Soliman, K. Kimura, F. Hirayama, K. Uekama, H.M. El-Sabbagh, A.H. Abd El-Gawad and F.M. Hashim: Int. J. Pharm. 149, 73 (1997).
T. Horikawa, F. Hirayama and K. Uekama: J. Pharm. Pharmacol. 47, 124 (1995).
Y. Ikeda, K. Kimura, F. Hirayama, H. Arima and K. Uekama: J. Contrl. Rel. 66, 271 (2000).
K. Minami, F. Hirayama and K. Uekama: J. Pharm. Sci. 87, 715 (1998).
H. Arima, F. Kihara, F. Hirayama and K. Uekama: Bioconj. Chem. 12, 476 (2001).
K. Miyake, T. Irie, H. Arima, F. Hirayama, K. Uekama, M. Hirano and Y. Okamoto: Int. J. Pharm. 179, 237 (1999).
K. Miyake, H. Arima, T. Irie, F. Hirayama and K. Uekama: Bio. Pharm. Bull. 22, 66 (1999).
H. Arima, K. Yunomae, K. Miyake, T. Irie, F. Hirayama and K. Uekama: J. Pharm. Sci. 90, 690 (2001).
K. Uekama, Y. Hieda, F. Hirayama, H. Arima, M. Sudoh, A. Yagi and H. Terashima: Pharm. Res. 18, 1578 (2001).
H. Arima, K. Yunomae, F. Hirayama and K. Uekama: J. Pharmacol. Exp. Ther. 297, 547 (2001).
F. Hirayama, Z. Wang and K. Uekama: Pharm. Res. 11, 1766 (1994).
F. Hirayama, M. Usami, K. Kimura and K. Uekama: Eur. J. Pharm. Sci. 5, 23 (1997).
K. Kimura, F. Hirayama, H. Arima and K. Uekama: Pharm. Res. 16, 1729 (1999).
T. Irie and K. Uekama: J. Pharm. Sci. 86, 147 (1997).
K. Tokihiro, H. Arima, S. Tajiri, T. Irie, F. Hirayama and K. Uekama: J. Pharm. Pharmacol. 52, 911 (2000).
K. Uekama, K. Minami and F. Hirayama: J. Med. Chem. 40, 2755 (1997).
H. Yano, F. Hirayama, H. Arima and K. Uekama: J. Pharm. Sci. 90, 493 (2001).
H. Yano, F. Hirayama, H. Arima and K. Uekama: J. Pharm. Sci. 90, 2103 (2001).
H. Yano, F. Hirayama, M. Kamada, H. Arima and K. Uekama: J. Control. Rel. 79, 103 (2002).
H. Gonzalez, S.J. Hwang and M.E. Davis: Bioconj. Chem. 10, 1068 (1999).
M.-Q. Zhang and D.C. Rees: Exp. Opin. Ther. Patents 9, 1697 (1999).
Rights and permissions
About this article
Cite this article
Uekama, K. Recent Aspects of Pharmaceutical Application of Cyclodextrins. Journal of Inclusion Phenomena 44, 3–7 (2002). https://doi.org/10.1023/A:1023007032444
Issue Date:
DOI: https://doi.org/10.1023/A:1023007032444